Published in Am J Psychiatry on May 01, 2003
Psychiatric comorbidities and schizophrenia. Schizophr Bull (2008) 2.69
How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull (2009) 1.69
Comorbidity and pathophysiology of obsessive-compulsive disorder in schizophrenia: is there evidence for a schizo-obsessive subtype of schizophrenia? J Psychiatry Neurosci (2005) 1.49
The 5-year course of obsessive-compulsive symptoms and obsessive-compulsive disorder in first-episode schizophrenia and related disorders. Schizophr Bull (2011) 0.98
Obsessive compulsive symptoms in the psychosis prodrome: correlates of clinical and functional outcome. Schizophr Res (2008) 0.96
Obsessive-Compulsive Disorder, Psychosis, and Bipolarity: A Longitudinal Cohort and Multigenerational Family Study. Schizophr Bull (2014) 0.94
Obsessive-compulsive disorder comorbidity: clinical assessment and therapeutic implications. Front Psychiatry (2011) 0.86
Prevalence of obsessive compulsive symptoms among patients with schizophrenia. Ind Psychiatry J (2009) 0.78
Interventions for obsessive compulsive symptoms in people with schizophrenia. Cochrane Database Syst Rev (2005) 0.78
Person-centered child and adolescent psychiatric care. Int J Integr Care (2010) 0.75
Frequency and severity of obsessive-compulsive symptoms/disorders, violence and suicidal in schizophrenic patients. Iran Red Crescent Med J (2012) 0.75
Evidence for a Shared Etiological Mechanism of Psychotic Symptoms and Obsessive-Compulsive Symptoms in Patients with Psychotic Disorders and Their Siblings. PLoS One (2015) 0.75
Insight into obsessive-compulsive symptoms and awareness of illness in adolescent schizophrenia patients with and without OCD. Child Psychiatry Hum Dev (2007) 0.75
Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study. J Am Acad Child Adolesc Psychiatry (2002) 1.75
Preferential aggregation of obsessive-compulsive spectrum disorders in schizophrenia patients with obsessive-compulsive disorder. Can J Psychiatry (2006) 1.43
Attenuation of olanzapine-induced weight gain with reboxetine in patients with schizophrenia: a double-blind, placebo-controlled study. Am J Psychiatry (2003) 1.24
The neuropsychological basis of insight in first-episode schizophrenia: a pilot metacognitive study. Schizophr Res (2004) 1.21
Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment. CNS Drugs (2004) 1.16
Olanzapine-induced weight gain in patients with first-episode schizophrenia: a double-blind, placebo-controlled study of fluoxetine addition. Am J Psychiatry (2002) 1.01
H-coil repetitive transcranial magnetic stimulation for treatment resistant major depressive disorder: An 18-week continuation safety and feasibility study. World J Biol Psychiatry (2012) 0.99
Global functional connectivity deficits in schizophrenia depend on behavioral state. J Neurosci (2011) 0.99
Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial. Biol Psychiatry (2006) 0.98
Cognition in young schizophrenia outpatients: comparison of first-episode with multiepisode patients. Schizophr Bull (2007) 0.96
Functional and structural neural indices of risk aversion in obsessive-compulsive disorder (OCD). Psychiatry Res (2012) 0.96
Attenuating effect of reboxetine on appetite and weight gain in olanzapine-treated schizophrenia patients: a double-blind placebo-controlled study. Psychopharmacology (Berl) (2007) 0.96
Memantine for treatment-resistant OCD. Am J Psychiatry (2005) 0.95
Obsessive-compulsive symptoms in schizophrenia: implications for future psychiatric classifications. Compr Psychiatry (2011) 0.95
Barotrauma vis-a-vis the "chronic otitis media syndrome": two conditions with middle ear gas deficiency Is secretory otitis media a contraindication to air travel? Ann Otol Rhinol Laryngol (2003) 0.93
Repetitive transcranial magnetic stimulation in the treatment of depression in adolescents: an open-label study. J ECT (2008) 0.92
Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot study. J Clin Psychopharmacol (2003) 0.92
Comparison of clinical characteristics and comorbidity in schizophrenia patients with and without obsessive-compulsive disorder: schizophrenic and OC symptoms in schizophrenia. J Clin Psychiatry (2003) 0.90
The effect of famotidine addition on olanzapine-induced weight gain in first-episode schizophrenia patients: a double-blind placebo-controlled pilot study. Eur Neuropsychopharmacol (2004) 0.90
Mirtazapine - a multifunctional drug: low dose for akathisia. CNS Spectr (2011) 0.90
Would a switch from typical antipsychotics to risperidone be beneficial for elderly schizophrenic patients? A naturalistic, long-term, retrospective, comparative study. J Clin Psychopharmacol (2002) 0.90
Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study. Schizophr Res (2011) 0.90
Obsessive musical hallucinations in a schizophrenia patient: psychopathological and FMRI characteristics. CNS Spectr (2011) 0.89
Leadership as a component of crowd control in a hospital dealing with a mass-casualty incident: lessons learned from the October 2000 riots in Nazareth. Prehosp Disaster Med (2008) 0.89
Effect of the 5-HT2 antagonist mianserin on cognitive dysfunction in chronic schizophrenia patients: an add-on, double-blind placebo-controlled study. Eur Neuropsychopharmacol (2003) 0.88
Diminished language lateralization in schizophrenia corresponds to impaired inter-hemispheric functional connectivity. Schizophr Res (2011) 0.88
rTMS for adolescents: Safety and efficacy considerations. Psychiatry Res (2010) 0.87
Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine-betahistine combination. Psychopharmacology (Berl) (2012) 0.86
Acute antipsychotic-induced akathisia revisited. Br J Psychiatry (2010) 0.86
Does the Internet offer social opportunities for individuals with schizophrenia? A cross-sectional pilot study. Psychiatry Res (2012) 0.85
The neuropsychological basis of competence to consent in first-episode schizophrenia: a pilot metacognitive study. Biol Psychiatry (2005) 0.85
Effect of the selective norepinephrine reuptake inhibitor reboxetine on cognitive dysfunction in schizophrenia patients: an add-on, double-blind placebo-controlled study. Isr J Psychiatry Relat Sci (2009) 0.85
Co-morbid social phobia in schizophrenia. Int J Soc Psychiatry (2009) 0.84
Aripiprazole in schizophrenia patients with comorbid obsessive-compulsive symptoms: an open-label study of 15 patients. J Clin Psychiatry (2008) 0.84
Relationship between antidepressants and IGF-1 system in the brain: possible role in cognition. Eur Neuropsychopharmacol (2007) 0.84
Repetitive transcranial magnetic stimulation in depressed adolescents: experience, knowledge, and attitudes of recipients and their parents. J ECT (2012) 0.84
Learned irrelevance is disrupted in first-episode but not chronic schizophrenia patients. Behav Brain Res (2005) 0.83
Neurological soft signs in schizophrenia patients with obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci (2007) 0.83
Adenosine A2A-receptor antagonism and pathophysiology of Parkinson's disease and drug-induced movement disorders. Eur Neurol (2011) 0.83
Awareness of illness and insight into obsessive-compulsive symptoms in schizophrenia patients with obsessive-compulsive disorder. J Nerv Ment Dis (2007) 0.83
Clinical characteristics of schizotypal-related obsessive-compulsive disorder. Psychiatry Res (2008) 0.82
Comprehension and companionship in the emergency department as predictors of treatment adherence. Australas Psychiatry (2012) 0.82
Suicidal behavior in minors-diagnostic differences between children and adolescents. J Dev Behav Pediatr (2012) 0.82
Gender differences in electroconvulsive therapy: a retrospective chart review. J Affect Disord (2005) 0.82
Role of a medical students' association in improving the curriculum at a faculty of health sciences. Med Teach (2002) 0.82
Obsessive-compulsive disorder in elderly schizophrenia patients. J Psychiatr Res (2006) 0.82
Familial aggregation of schizophrenia-spectrum disorders and obsessive-compulsive associated disorders in schizophrenia probands with and without OCD. Am J Med Genet B Neuropsychiatr Genet (2005) 0.81
How many pins? A case report of a girl who swallowed more than 50 straight pins in a suicide attempt. Int J Adolesc Med Health (2005) 0.81
COMT Val158Met polymorphism in schizophrenia with obsessive-compulsive disorder: a case-control study. Neurosci Lett (2005) 0.81
Dream content of schizophrenic, nonschizophrenic mentally ill, and community control adolescents. Adolescence (2003) 0.81
Acute otitis media and mastoid growth. Acta Otolaryngol (2006) 0.80
Electroconvulsive therapy and transcranial magnetic stimulation: can they be considered valid modalities in the treatment of pediatric mood disorders? Child Adolesc Psychiatr Clin N Am (2006) 0.80
Age-of-onset of schizophrenic and obsessive-compulsive symptoms in patients with schizo-obsessive disorder. Psychiatry Res (2012) 0.80
Is secretory otitis media a single disease entity? Ann Otol Rhinol Laryngol (2003) 0.80
The effect of betahistine, a histamine H1 receptor agonist/H3 antagonist, on olanzapine-induced weight gain in first-episode schizophrenia patients. Int Clin Psychopharmacol (2005) 0.80
Obsessive-compulsive symptom dimensions in schizophrenia patients with comorbid obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.80
Chronic lithium treatment affects rat brain and serum dehydroepiandrosterone (DHEA) and DHEA-sulphate (DHEA-S) levels. Int J Neuropsychopharmacol (2004) 0.80
Long-term follow-up of adolescents with resistant depression treated with repetitive transcranial magnetic stimulation. J ECT (2012) 0.80
The effect of reboxetine co-administration with olanzapine on metabolic and endocrine profile in schizophrenia patients. Psychopharmacology (Berl) (2013) 0.79
Behavioral effects of opioid subtypes compared with benzodiazepines in the staircase paradigm. Behav Brain Res (2006) 0.79
Stimulants improve theory of mind in children with attention deficit/hyperactivity disorder. J Psychopharmacol (2013) 0.79
The effect of age on frontal lobe related cognitive functions of unmedicated depressed patients. J Affect Disord (2011) 0.79
Switching elderly chronic psychotic patients to olanzapine. Int J Neuropsychopharmacol (2004) 0.78
Estradiol modulates uterine 18 kDa translocator protein gene expression in uterus and kidney of rats. Mol Cell Endocrinol (2009) 0.78
Effect of L-tryptophan on memory in patients with schizophrenia. J Nerv Ment Dis (2003) 0.78
The antinociceptive properties of reboxetine in acute pain. Eur Neuropsychopharmacol (2009) 0.78
Negative bodily self in suicide attempters. Suicide Life Threat Behav (2006) 0.78
A bit of shame and a proud sham. Brain Stimul (2012) 0.78
Positive family history is associated with persistent elevated emotional distress in schizophrenia: evidence from a 16-month follow-up study. Psychiatry Res (2007) 0.78
Familiality in a five-factor model of schizophrenia psychopathology: findings from a 16-month follow-up study. Psychiatry Res (2005) 0.77
Olanzapine-sertraline combination in schizophrenia with obsessive-compulsive disorder. J Clin Psychiatry (2003) 0.77
Hyperglycemia from olanzapine treatment in adolescents. J Child Adolesc Psychopharmacol (2003) 0.77
Suicidal tendencies and body image and experience in anorexia nervosa and suicidal female adolescent inpatients. Psychother Psychosom (2002) 0.77
Olanzapine vs. haloperidol in the treatment of elderly chronic schizophrenia patients. Prog Neuropsychopharmacol Biol Psychiatry (2002) 0.77
Decreased circulatory levels of neuroactive steroids in behaviourally more extremely affected rats subsequent to exposure to a potentially traumatic experience. Int J Neuropsychopharmacol (2006) 0.77
Mianserin for the rapid improvement of chronic akathisia in a schizophrenia patient. Eur Psychiatry (2004) 0.77
Age-related differences in the side effect profile of citalopram. Prog Neuropsychopharmacol Biol Psychiatry (2003) 0.77
Reasons for referral for electroconvulsive therapy: a comparison between adolescents and adults. Australas Psychiatry (2008) 0.77
Obsessive-compulsive disorder in bipolar disorder patients with first manic episode. J Affect Disord (2006) 0.76
Comparison of symptoms and treatments of adults and adolescents with borderline personality disorder. Int J Adolesc Med Health (2006) 0.76